Basic info
Industry
biotechnology research
Sectors
clinical trial
Biotechnology
biotechnology
Health Care
China
drug development
CNS
Oncology
late-stage
Biopharma
biomarker
Date founded
2011
Funding rounds raised
Total raised
$83M
from 8 investors over 8 rounds
D
Denovo Biopharma raised $46M on December 10, 2020
Investors: 盈科创新资产管理有限公司 and Sangel Capital
D
Denovo Biopharma raised $83M on June 29, 2020
Investors: 中金公司
D
Denovo Biopharma raised $43M on October 31, 2019
Investors: Sangel Capital and 广州越秀产业投资基金管理有限公司
D
Denovo Biopharma raised undisclosed on July 1, 2015
Investors: Zhejiang Xianju Pharmaceutical Co., Ltd., Goldstone Investment Ltd. and 广州越秀产业投资基金管理有限公司